These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 35070429

  • 1. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
    Zhao X, Zhao J, Tao L, Pan Y, Yang L, Zhang X, Yuan J, Zhu H.
    J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
    [Abstract] [Full Text] [Related]

  • 2. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J, Zhang Z, Zhou H, Leng C, Hou B, Zhou C, Hu X, Wang J, Chen X.
    BMC Cancer; 2020 Oct 31; 20(1):1047. PubMed ID: 33129301
    [Abstract] [Full Text] [Related]

  • 3. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma.
    Yang X, Ni H, Lu Z, Zhang J, Zhang Q, Ning S, Qi L, Xiang B.
    BMC Cancer; 2023 Jan 05; 23(1):10. PubMed ID: 36600214
    [Abstract] [Full Text] [Related]

  • 4. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
    Chen J, Luo Y, Xi X, Li H, Li S, Zheng L, Yang D, Cai Z.
    Front Oncol; 2022 Jan 05; 12():931140. PubMed ID: 36465354
    [Abstract] [Full Text] [Related]

  • 5. Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma.
    Sun B, Ji WD, Wang WC, Chen L, Ma JY, Tang EJ, Lin MB, Zhang XF.
    Front Genet; 2023 Jan 05; 14():1265866. PubMed ID: 38028589
    [Abstract] [Full Text] [Related]

  • 6. Relationship between circulating tumor cells undergoing EMT and short-term efficacy following interventional treatment in patients with hepatocellular carcinoma.
    Chen M, Xu R, Wu L, Chen X.
    J Interv Med; 2020 Sep 05; 3(3):146-150. PubMed ID: 34805926
    [Abstract] [Full Text] [Related]

  • 7. Effect of various hepatectomy procedures on circulating tumor cells in postoperative patients: a case-matched comparative study.
    Lei Y, Wang X, Tian Y, Xu R, Pei J, Fu Y, Sun H, Wang Y, Zheng P, Xia F, Wang J.
    Front Med (Lausanne); 2023 Sep 05; 10():1209403. PubMed ID: 37841010
    [Abstract] [Full Text] [Related]

  • 8. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
    Sun YF, Guo W, Xu Y, Shi YH, Gong ZJ, Ji Y, Du M, Zhang X, Hu B, Huang A, Chen GG, Lai PBS, Cao Y, Qiu SJ, Zhou J, Yang XR, Fan J.
    Clin Cancer Res; 2018 Feb 01; 24(3):547-559. PubMed ID: 29070526
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.
    Cheng Y, Luo L, Zhang J, Zhou M, Tang Y, He G, Lu Y, Wang Z, Pan M.
    J Gastrointest Surg; 2019 Dec 01; 23(12):2354-2361. PubMed ID: 30805878
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.
    Yin LC, Luo ZC, Gao YX, Li Y, Peng Q, Gao Y.
    Biomed Res Int; 2018 Dec 01; 2018():3789613. PubMed ID: 30046595
    [Abstract] [Full Text] [Related]

  • 12. Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma.
    Bai T, Mai R, Ye J, Chen J, Qi L, Tang J, Wei M, Zhang L, Chen Z, Tang Z, Li L, Wu F.
    Transl Cancer Res; 2020 Mar 01; 9(3):1384-1394. PubMed ID: 35117486
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of preoperative circulating tumor cells for hepatocellular carcinoma with portal vein tumor thrombosis: A propensity score analysis.
    Yu JJ, Li YN, Shu C, Yang HY, Huang Z, Tao R, Chen YY, Chen XP, Xiao W.
    J Cancer Res Clin Oncol; 2023 Sep 01; 149(11):8981-8991. PubMed ID: 37160624
    [Abstract] [Full Text] [Related]

  • 14. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma.
    Luo Q, Wang C, Peng B, Pu X, Cai L, Liao H, Chen K, Zhang C, Cheng Y, Pan M.
    Front Oncol; 2020 Sep 01; 10():1758. PubMed ID: 33224869
    [Abstract] [Full Text] [Related]

  • 15. Postoperative circulating tumor cells: An early predictor of extrahepatic metastases in patients with hepatocellular carcinoma undergoing curative surgical resection.
    Sun YF, Wang PX, Cheng JW, Gong ZJ, Huang A, Zhou KQ, Hu B, Gao PT, Cao Y, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR.
    Cancer Cytopathol; 2020 Oct 01; 128(10):733-745. PubMed ID: 32501632
    [Abstract] [Full Text] [Related]

  • 16. Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma.
    Zhang Q, Xing W, Zhang J, Hu J, Qi L, Xiang B.
    Onco Targets Ther; 2021 Oct 01; 14():1543-1552. PubMed ID: 33688202
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype.
    Yu JJ, Shu C, Yang HY, Huang Z, Li YN, Tao R, Chen YY, Chen Q, Chen XP, Xiao W.
    Front Oncol; 2021 Oct 01; 11():734564. PubMed ID: 34722281
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.